$FULC

Fulcrum Therapeutics Inc

  • NASDAQ
  • Health Technology
  • Pharmaceuticals: Major
  • Manufacturing
  • Medicinal and Botanical Manufacturing

PRICE

$7.64 -

Extented Hours

VOLUME

395,250

DAY RANGE

7.23 - 7.71

52 WEEK

6.85 - 33.1

Join Discuss about FULC with like-minded investors

profile
@sperry #droscrew
recently

Maybe KZR not done pumping it yet. A kinda similar play happened on ticker FULC few months ago. Biotech (that makes little/no money), very high institutional ownership, news leading to big gap up, very high PTs announced, then kept going up. Still hasnt closed gap months later. A perfect short trap imo

96 Replies 14 πŸ‘ 11 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$FULC daily looks interesting

87 Replies 7 πŸ‘ 12 πŸ”₯

profile
@marketjay #marketassasins
recently

Current plays that did not make the main watchlist but are going to be intraday watches for momentum along with pre market scans FULC, and OPCH

107 Replies 9 πŸ‘ 14 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$FULC PT raised to $46 from $20 at Piper

75 Replies 12 πŸ‘ 11 πŸ”₯

ST
@stevengo #StockTraders.NET
recently

Keeping an eye on $FULC, was expecting a red move

47 Replies 6 πŸ‘ 12 πŸ”₯

ST
@stevengo #StockTraders.NET
recently

$FULC sucker!!

113 Replies 7 πŸ‘ 8 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$FULC has $BTBT like price action

144 Replies 14 πŸ‘ 7 πŸ”₯

ST
@stevengo #StockTraders.NET
recently

It is def Flucking me right now. lol > @Chano said: $FULC Fulcking shorts

136 Replies 8 πŸ‘ 14 πŸ”₯

profile
@Chano #StockTraders.NET
recently

$FULC Fulcking shorts

142 Replies 8 πŸ‘ 8 πŸ”₯

ST
@stevengo #StockTraders.NET
recently

I'mm still short $FULC from ealrier in the week. Will looking for a fade or to cut the positoin.

131 Replies 6 πŸ‘ 7 πŸ”₯

profile
@marketjay #marketassasins
recently

FULC heavy momentum

115 Replies 8 πŸ‘ 13 πŸ”₯

ST
@stevengo #StockTraders.NET
recently

Este HP bounced!! > @Chano said: $FULC starting to look interesting

79 Replies 12 πŸ‘ 15 πŸ”₯

profile
@Chano #StockTraders.NET
recently

$FULC starting to look interesting

116 Replies 15 πŸ‘ 7 πŸ”₯

ST
@stevengo #StockTraders.NET
recently

Need $FULC to break this level. Short from yesterday

43 Replies 13 πŸ‘ 13 πŸ”₯

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Thursday, August 12, 2021 Futures Up/Down % Last Dow 40.00 0.12% 35,413 S&P 500 2.25 0.05% 4,442 Nasdaq 5.50 0.04% 15,025 Another day, another record high for the Dow and S&P 500 as futures are pointing to a slightly higher open, building on the ongoing upside momentum that pushed the S&P 500 to its 45th all-time high Wednesday. Both the Dow Jones Industrial Average and S&P 500 are coming off all-time bests as consumer prices (CPI) data indicated U.S. inflation was in-line with estimates, raising hopes that growth may have peaked, while sectors tied to economic growth such as industrials, materials and metals advanced a second day on the heels of the passage of a large infrastructure bill. The July consumer price index increased 0.5% last month after climbing 0.9% in June, though on a YoY basis was above 5% again (ahead of today’s PPI data at 8:30 AM ET). Meanwhile, two Fed members (George and Kaplan) each said the central bank should announce its timeline to reduce its massive bondholding, with Kaplan calling for it to begin next month, with tapering to begin in October. Healthcare was also a drag on markets as S&P components MRNA and PFE fell after the drug regulator of the European Union said it was looking into new possible side-effects of mRNA COVID-19 shots. Asian shares dropped for the first time this week as China stepped up scrutiny of its insurance technology platforms while European stocks drift on mixed earnings results. The Nikkei Index slipped -55 points to 28,015, the Shanghai Index slid -7 points to 3,524, and the Hang Seng Index dropped -142 points (0.535) to settle at 26,517. In Europe, the German DAX is up over 60 points to 15,888, while the FTSE 100 is down a few points at 7,210. Events Calendar for Today 8:30 AM ET Weekly Jobless Claims…est. 375K 8:30 AM EST Continuing Claims…est. 2.88M 8:30 AM ET Producer Price Index (PPI) MoM for July…est. 0.6% 8:30 AM ET PPI Ex: Food & Energy (core) MoM for July…est. 0.5% 8:30 AM ET Producer Price Index (PPI) YoY for July…est. 7.3% 8:30 AM ET PPI Ex: Food & Energy (core) YoY for July…est. 5.6% 10:30 AM ET Weekly EIA Natural Gas Inventory Data 1:00 PM ET U.S. to sell $27 bln in 30-year bonds Earnings Calendar: Earnings Before the Open: AVXL, AZEK, BDR, BODY, BR, BTTR, CELH, EFOI, EMAN, EYE, FSTX, GRWG, HOOK, KELYA, MDP, MIDD, MKTW, NYC, PGTI, SOHO, TAST, UP, UTZ, VERU Earnings After the Close: ABNB, ACHV, AFIB, APDN, ASTR, AWH, BBI, BIOL, BLBD, BOXL, BW, CAPR, CODX, CRMD, DASH, DCO, DIS, EAR, FIGS, FLO, FRGI, HOFV, ICCC, INTZ, IPWR, KINS, LAZR, LIVX, LMB, LVOX, LZ, MOTS, OPGN, PHUN, PTE, SFE, SGHT, SOFI, TLMD, TPCS, VIVE, WISH, XL Other Key Events: BTIG HIMSS Digital Health Booth Tour (virtual), 8/11-8/12 Canaccord Genuity 41st Annual Growth Conference (virtual), 8/10-8/12 Cowen Annual Communications Infrastructure Hybrid Summit, 8/9-8/12 Cowen 9th Annual Internet & Media Bus Tour (virtual), 8/9-8/13 Credit Suisse 4th Annual FinTech Conference (virtual), 8/11-8/13 JPMorgan Auto Conference (virtual), 8/11-8/12 KeyBanc Capital Markets Technology Leadership Virtual Forum, 8/9-8/12 Oppenheimer 24th Annual Technology, Internet & Comm Conference (virtual), 8/10-8/12 Piper Biotech Virtual Tour, 8/10-8/12 UBS Financial Services Conference (virtual), 8/10-8/12 Market Closing Prices Yesterday The S&P 500 Index gained 10.95 points, or 0.25%, to 4,447.70 The Dow Jones Industrial Average rose 220.30 points, or 0.62%, to 35,484.97 The Nasdaq Composite slipped -22.95 points, or 0.16%, to 14,765.14 The Russell 2000 Index advanced 10.98 points, or 0.49% to 2,250.34 Macro Up/Down Last Nymex -0.08 69.17 Brent -0.04 71.40 Gold 1.10 1,752.80 EUR/USD -0.0002 1.1737 JPY/USD -0.02 110.41 10-Year Note -0.008 1.351% World News The International Energy Agency (IEA) cut its outlook for global oil demand β€œsharply” for the rest of 2021 as the resurgence of coronavirus rocks major consumers and predicted a new surplus in 2022. The IEA cut its 2021 global oil demand growth forecast by 100,000 barrels a day, while upgrading its 2022 forecast by 200,000 barrels a day Eurozone Jun Industrial Production: m/m -0.3% vs -0.2% consensus; y/y 9.7% vs 10.4% consensus UK Q2 GDP: q/q 4.8% in-line; y/y 22.2% vs 22.1% consensus; UK Jun GDP: 1.0% vs 0.8% consensus; UK June Trade Balance: -Β£11.99b vs -Β£9.1b consensus; K June Ind Production m/m 0.7% vs 0.3% consensus, y/y 8.3% vs 9.4% consensus Sector News Breakdown Consumer DoorDash ($DASH) is said to have held talks to purchase Instacart over the past two months that may have valued the grocery delivery company at $40B to $50B. The talks felt apart in recent weeks at least partly over regulatory concerns, according to a report in The Information https://bit.ly/2VKi4F5 Core-Mark Holding ($CORE) said the waiting period under the HSR act for Performance Food Group’s (PFGC) planned purchased expired on Aug. 9 and the closing conditions for the deal have been satisfied Fisker Inc ($FSR) announces private offering of $600 mln 5-yr convertible notes Nio ($NIO) Q2 non-GAAP EPS loss (-$0.03) vs. est. loss (-$0.11); Revenue of $1.31B (+127% Y/Y) beats by $20M; said achieved a record-high quarterly delivery of 21,896 vehicles in Q2, followed by 7,931 vehicles in July, bringing the cumulative deliveries of NIO vehicles to 125,528 as of July 31, 2021 Blink Charging ($BLNK) 2Q EPS ($0.32) vs est. ($0.16) on revs $4.4Mm vs est. $2.6Mm eBay Inc. ($EBAY) Q2 adj EPS $0.99 vs. est. $0.95; Q2 revs $2.7B vs. est. $3.00B; expands share repurchase authorization by an additional $3B; entered agreement to sell about 135M shares of eBay’s Adevinta stock to Permira for over $2.4B, reducing ownership to 33%; announced an agreement to sell 80.01% of eBay Korea business to eMart for about $3B; guides Q3 revs $2.42B-$2.47B vs. est. $2.92B; annual active sellers grew by 5%, for total of 19M global active sellers Fossil Group ($FOSL) 2Q EPS ($0.02) on sales $411Mm; sees 3Q net sales +5-10%; guides FY net sales growth to approx +14-17%; Lordstown Motors ($RIDE) 2Q EPS ($0.61) vs est. ($0.49); pursuing external capital sources including debt and equity-linked securities; sees FY op exp $95-105Mm, expects to end 3Q with liquidity between 225-275Mm cash and equivalents without any funds from a capital raise Utz Brands ($UTZ) Q2 adj EPS 13c vs. est. 15c; Q2 revs $299.2M vs. est. $290.29M; sees FY 2021 adjusted shr $0.55 to $0.60; believes that consumer demand for its products will remain strong in second half of fiscal 2021; says continue to expect fiscal 2021 net sales consistent with fiscal 2020 pro forma net sales Vroom ($VRM) Q2 adj EPS loss (-$0.48), in-line with consensus; Q2 revs $761.89M vs. est. $637.99M; for Q2, had18,268 ecommerce units sold, up 172% YoY; Ecommerce revenue of $579.7 million, up 230% YoY; Ecommerce gross profit of $49.6 million, up 588% YoY Energy Array Technologies ($ARRY) 2Q EPS $0.00 vs est. $0.01 on revs $202.8Mm vs est. $231Mm; guides FY revs $850-940Mm vs est. $1B, sees FY adj EPS $0.15-0.25 vs est. $0.37 EnerSys ($ENS) Q adj EPS $1.25 vs est. $1.20 on revs $814.9Mm vs est. $810.5Mm, backlog grew $157Mm; guides 2Q adj EPS $1.03-1.13 vs est. $1.28 Canadian Solar ($CSIQ) Q2 EPS $0.18 vs. est. loss (-$0.30); Q2 revs $1.43B vs. est. $1.43B; Q2 solar module shipments of 3.7 GW, top end of 3.5 GW to 3.7 GW guidance; sees Q3 revs $1.2B-$1.4B vs. est. $1.62B; reducing its full year 2021 total module shipment guidance to 16 GW to 17 GW; reiterates its project sales guidance and total battery storage shipment guidance for FY 2021; carve-out IPO of CSI solar subsidiary remains on track Financials AllianceBernstein L.P. ($AB) preliminary assets under management increased to $748 billion during July 2021 from $738 billion at the end of June. Market appreciation and modest firmwide net inflows drove the 1% increase. Manning & Napier, Inc. ($MN) reported preliminary assets under management (β€œAUM”) as of July 31, 2021 of $22.5 billion, compared with $22.3 billion at June 30, 2021 Victory Capital Holdings, Inc. ($VCTR) reported assets under management (AUM) of $162.9 billion as of July 31, 2021. Opendoor Technologies (OPEN) Q2 EPS loss (-$0.24) vs. est. loss (-$0.34); Q2 revs $1.2B vs. est. $1.09B; Gross profit of $159 million, up 64% versus 1Q21; gross margin of 13.4%, up 40 basis points versus 1Q21; Adjusted EBITDA of $26 million versus ($2) million in 1Q21; adjusted EBITDA margin of 2.2% versus (0.3%) in 1Q21; sees Q3 revenue $1.8B-$1.9B vs. est. $1.52B Healthcare In vaccine news, NBC reports that the FDA would authorize a third shot of coronavirus vaccine as soon as Thursday for certain people with weakened immune systems. The decision to expand the emergency use of the vaccines from Moderna ($MRNA) and the Pfizer ($PFE)/BioNTech ($BNTX) shots Amwell ($AMWL) Q2 EPS loss (-$0.15) vs. est. loss (-$0.19); Q2 revs $60.2M vs. est. $61.7M; Q2 gross margins increased 600 bps to 44% of revenue versus 38% last quarter; said total visits of 1.3 million versus 1.6 million last quarter; lowers year revs to $252M-$262M from $260M-$270M and narrows year adj Ebitda loss view Fulcrum Therapeutics ($FULC)6M share secondary priced at $19.00 GoHealth ($GOCO) 2Q EPS ($0.12) vs est. ($0.04) on revs $196.9Mm vs est. $175.1Mm; guides FY revs $1.2-1.3B vs est. $1.24B, sees FY adj EBITDA $300-330Mm Hims & Hers ($HIMS) Q2 EPS loss (-$0.05) vs. est. loss (-$0.10); Q2 revs $60.7M vs. est. $56.49M; sees Q3 revs $69M-$71M vs. est. $58.31M and sees year revs $251M-$255M vs. est. $226.3M Xeris Pharmaceuticals ($XERS) announced it has received U.S. FDA clearance for phase 1 clinical trials for its hypothyroidism treatment Industrials & Materials Apogee Enterprises ($APOG) announced plans to realign and simplify its business structure to β€œbring a stronger focus to serving customers, enable a more competitive cost model, and better position the company for future growth and improved profitability; now expects to achieve $20M-$30M of annualized savings by the end of fiscal 2023 Royal Gold ($RGLD) 4Q EPS $1.25 vs est. $0.92 on revs $168Mm vs est. $165Mm; guides 1Q stream segment sales 62,000-67,000 GEOs with qtr-end inventory 22,000-27,000 GEOs Gates Industrial ($GTES) 25M share Secondary priced at $16.00

58 Replies 14 πŸ‘ 8 πŸ”₯

ST
@stevengo #StockTraders.NET
recently

Def Stress free parcero > @Chano said: I should have focused on $FULC instead, what a stress free fader trade

66 Replies 8 πŸ‘ 15 πŸ”₯

ST
@stevengo #StockTraders.NET
recently

$FULC is working great!!

55 Replies 7 πŸ‘ 9 πŸ”₯

profile
@Math #StockTraders.NET
recently

$FULC and $CWBR were the ones

106 Replies 13 πŸ‘ 11 πŸ”₯

profile
@Chano #StockTraders.NET
recently

I should have focused on $FULC instead, what a stress free fader trade

42 Replies 12 πŸ‘ 13 πŸ”₯

ST
@stevengo #StockTraders.NET
recently

Awesome $FULC

76 Replies 12 πŸ‘ 9 πŸ”₯

ST
@stevengo #StockTraders.NET
recently

Oh and $FULC > @stevengo said: $FUBO, $VSCO, $MRNA, $MARA, $TSLA.

64 Replies 10 πŸ‘ 13 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

☝️ Has that $FULC look to it from yday

79 Replies 10 πŸ‘ 13 πŸ”₯

ST
@stevengo #StockTraders.NET
recently

reshorted > @stevengo said: ss $FULC

82 Replies 15 πŸ‘ 12 πŸ”₯

ST
@stevengo #StockTraders.NET
recently

Stopped > @stevengo said: ss $FULC

99 Replies 6 πŸ‘ 8 πŸ”₯

ST
@stevengo #StockTraders.NET
recently

No, i'm to hard headed. lol > @maletone said: Hope you guys are avoiding $FULC short

79 Replies 13 πŸ‘ 12 πŸ”₯

profile
@maletone #StockTraders.NET
recently

Hope you guys are avoiding $FULC short

79 Replies 12 πŸ‘ 6 πŸ”₯

ST
@stevengo #StockTraders.NET
recently

Watching $FULC

111 Replies 14 πŸ‘ 14 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$FULC offering

92 Replies 7 πŸ‘ 12 πŸ”₯

profile
@Chano #StockTraders.NET
recently

looks like algos walked from $FULC

78 Replies 7 πŸ‘ 10 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$FULC widow maker

56 Replies 12 πŸ‘ 13 πŸ”₯

profile
@Chano #StockTraders.NET
recently

I am no expert here, but seems like IO which was a big red flag for me is largely responsible for this unstoppable trend on $FULC no single lower low after the morning flush

72 Replies 12 πŸ‘ 6 πŸ”₯

ST
@stevengo #StockTraders.NET
recently

Hopefully it washes out > @TraderXx said: am currently stuck in $FULC

44 Replies 8 πŸ‘ 10 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

am currently stuck in $FULC

93 Replies 12 πŸ‘ 13 πŸ”₯

AN
@andres168 #StockTraders.NET
recently

nasty there $fulc

137 Replies 10 πŸ‘ 13 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

and there she goes $FULC

82 Replies 10 πŸ‘ 14 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$FULC is better not to look for top on this one...

102 Replies 14 πŸ‘ 8 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$FULC rigged

103 Replies 11 πŸ‘ 9 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$FULC is a trap machine

86 Replies 14 πŸ‘ 9 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$FULC dangerous

139 Replies 10 πŸ‘ 7 πŸ”₯

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Tuesday, August 10, 2021 Futures Up/Down % Last Dow -19.00 0.05% 34,979 S&P 500 -0.25 0.02% 4,425 Nasdaq 17.50 0.12% 15,142 Stock markets are looking quiet again, as major averages have been holding near record highs but struggling for direction to start the week. Stronger economic data last Friday on the form of non-farm payrolls and declining unemployment helped boost sentiment about the economy, overshadowing any uncertainty over what impact the fast-spreading delta virus variant will have on the economy and comments from Federal Reserve officials about scaling back support. In Asian markets, The Nikkei Index gained 68 points to settle at 27,888, the Shanghai Index jumped 35 points to 3,529, and the Hang Seng Index gained 322 points (1.23%) to close at 26,605. In Europe, the German DAX is up around 25 points to 15,770, while the FTSE 100 is down a few points at 7,125. Today a fairly busy day of economic data, but all eyes fixed on the inflation reports coming up tomorrow (CPI) and on Thursday (PP), to see if the four-month spike in prices is indeed transitory as the Fed has pledged or if it is something more troubling for consumers down the line. Earnings season has begun to slow, with nearly 450 S&P companies having reported this quarter, with only some big retailers (WMT, TGT, HD, LOW) remaining. Trading ranges have remained in tight ranges of late, as summer doldrums have kicked in early. Market Closing Prices Yesterday The S&P 500 Index slipped -4.17 points, or 0.09%, to 4,432.35 The Dow Jones Industrial Average fell -106.66 points, or 0.30%, to 35,101.85 The Nasdaq Composite gained 24.42 points, or 0.16%, to 14,860.18 The Russell 2000 Index declined -12.95 points, or 0.58% to 2,234.81 Events Calendar for Today 6:00 AM ET NFIB Small Business Optimism for July 7:45 AM ET ICSC Weekly Retail Sales 8:30 AM ET Non-farm Productivity, prelim-Q2 8:30 AM ET Unit Labor Costs, prelim-Q2 8:55 AM ET Johnson/Redbook Weekly Sales 1:00 PM ET U.S. to sell $58 bln in 3-year notes 4:30 PM ET API Weekly Inventory Data Earnings Calendar: Earnings Before the Open: BSY, BTAI, CSPR, FULC, GTIM, IIVI, JBI, KPLT, LAND, LODE, MRNSD, MTNB, NAUT, OWL, SMID, SYY, TDG, TDW, VITL, VPG, VSH, VTNR Earnings After the Close: AIRG, AVGR, BVS, CHK, CLSD, COIN, COKE, CSSE, CURI, DAR, DOCS, EPAY, FTEK, GO, HCKT, HYRE, JAMF, KODK, KTCC, LPRO, LRN, MCFE, MEG, NARI, NVEE, OPFI, PANL, PAY, PAYS, PLBY, POSH, PUBM, SFT, SIEN, SMCI, TASK, TDUP, U, UPST, VEC, WW, ZETA Other Key Events: BTIG Biotechnology Conference 2021 (virtual), 8/9-8/10 Canaccord Genuity 41st Annual Growth Conference (virtual), 8/10-8/12 Cowen Annual Communications Infrastructure Hybrid Summit, 8/9-8/12 Cowen 9th Annual Internet & Media Bus Tour (virtual), 8/9-8/13 KeyBanc Capital Markets Technology Leadership Virtual Forum, 8/9-8/12 Oppenheimer 24th Annual Technology, Internet & Comm Conference (virtual), 8/10-8/12 Piper Biotech Virtual Tour, 8/10-8/12 Susquehanna 2021 Energy, Industrials & Airlines Conference (virtual), 8/10-8/11 UBS Financial Services Conference (virtual), 8/10-8/12 Wells Fargo 6th Annual FinTech & Technology Services Forum (virtual), 8/10-8/11 Macro Up/Down Last Nymex 1.05 67.51 Brent 0.84 69.88 Gold -1.00 1,728.90 EUR/USD -0.0018 1.1719 JPY/USD 0.24 110.53 10-Year Note +0.002 1.319% World News The NFIB Small Business Optimism Index was 99.7 vs. 103.3 consensus, and down from 102.5 in June. Germany Aug ZEW Sentiment4, well below the 56.7 consensus; conditions 29.3 vs 30.0 consensus; expectations decline for third time in a row; concerns over 4th wave of COVID affecting German economy in the Autumn Sector News Breakdown Consumer AMC Entertainment ($AMC) Q2 adj EPS loss (-$0.71) vs. est. loss (-$0.93); Q2 revs $444.7M vs. est. $381.28M; currently has liquidity availability of more than $2.0 billion; said welcomed more than 22 million guests back to theatres during Q2; said as of June 30, 2021, operated 593 domestic theatres & 335 international theatres Calloway ($ELY) 2Q adj EPS $0.36 vs est. $0.01 on revs $914Mm vs est. $753.1Mm; guides 3Q revs $775-790Mm vs est. $763Mm, sees 3Q adj EBITDA $51-58Mm vs est. $77.3Mm; guides FY revs $3.025-3.055B vs est. $2.84B, sees FY adj EBITDA $345-360Mm vs est. $295.3Mm CarLotz ($LOTZ) 2Q EPS ($0.06) vs est. ($0.20) on revs $50.8Mm vs est. $48.1Mm; withdraws previous FY21 outlook due to channel constraints Chegg Inc. ($CHGG) 2Q adj EPS $0.43 vs est. $0.37 on revs $198.5Mm vs est. $190.1Mm; guides 3Q revs $170-175Mm vs est. $173Mm; guides FY21 revs $805-815Mm vs est. $797.8Mm, sees FY adj EBITDA $295-300Mm vs est. $278.6Mm DoorDash ($DOOR) 2Q adj EPS $2.23 vs est. $2.09 on revs $662Mm vs est. $635.2Mm; guides FY sales +17-20% vs est. +14.5%, sees FY adj EPS $8.00-8.60 vs est. $8.50 Inter Parfums ($IPAR) 2Q EPS $0.71 vs est. $0.43 on revs $207.6Mm vs est. $207.6m; continues to see FY revs approx $750Mm vs est. $758.1Mm, EPS $1.95 vs est. $1.93 Nautilus ($NLS) Q1 EPS $0.43 vs. est. $0.30; Q1 revs $185M vs. est. $169.05M; said Q1 retail grew sales by 91% or 107% excluding Octane, delivering record net sales of $120 million, while Direct grew by 26%; sees Q2 revs $145M-$155M vs. est. $153.05M Original BARK ($BARK) 1Q adj EPS ($0.09) vs est. ($0.06) on revs $117.6Mm vs est. $116.8Mm; guides 2Q revs $122Mm vs est. $120.3Mm; reaffirms FY guide, sees FY revs $516Mm vs est. $516.5Mm Plant Fitness ($PLNT) Q2 adj EPS $0.21 vs. est. $0.23; Q2 revs $137.3M vs. est. $127.2M; ends second quarter with total membership of more than 14.8M and over 98% of stores open globally; Q2 adj EBITDA increased $64.8M to $55.6M from a loss of $9.3M in the prior year period; sees FY21 adj EPS $0.65-$0.70 vs. est. $0.94; sees FY21 revs $530M-$540M vs. est. $541.69M Purple Innovation ($PRPL) Q2 adj EPS $0.05 vs. est. $0.12; Q2 revs $182.6M vs. est. $181.8M; guides year revs $820M-$850M vs. est. $823.6M; sees year Ebitda $78M-$88M vs. est. $81.8M RealReal inc. ($REAL) Q2 EPS loss (-$0.50) vs. est. (-$0.47); Q2 revs $104.91M vs. est. $107.25M; Q2 GMV $350M; said trailing 12 months active buyers reached 730,000, an increase of 19% year-over-year and 48% compared to the same period in 2019; Orders reached 673K, an increase of 53% Y/Y and 33% compared to the same period in 2019. Tesla ($TSLA) sold 32,968 China-made vehicles in July, including 24,347 for export, the China Passenger Car Association (CPCA) said on Tuesday; local sales of China-made vehicles plunged 69% to 8,621 cars from 28,138 in June. Financials First Republic ($FRC) announces offering of 2M shares of common stock CoreCivic ($CXW) Q2 adj FFO $0.46; Q23 revs $464.6M vs. est. $466.1M; Adjusted EBITDA of $101.7M; sale of five non-core real estate assets for gross proceeds of $328.7 million SVB Financial ($SIVB)23M share Spot Secondary priced at $564.00 P. Carey ($WPC) 4.5M share Spot Secondary priced at $78.00 Healthcare BioCryst ($BCRX) announces offering of $200M of common stock, warrants Halozyme ($HALO) Q2 non-GAAP EPS $0.66 vs. est. $0.40; Q2 revs $136.5M vs. est. $103.16M; raises FY21 non-GAAP EPS view to $1.85-$2.00 from $1.55-$1.70 and boosts FY21 revenue view to $425M-$445M from $375M-$395M (est. $404.5M) citing the recent signing of a new collaboration and license agreement and strong year-to-date results Inovio Pharma ($INO) 2Q EPS ($0.39) vs est. ($0.25) on revs $273K; as of June 30, cash and equivalents & s-t investments were $443.7Mm, says continue to evaluate and assess impact of new covid strains Penumbra ($PEN) 2Q adj EPS $0.21 vs est. $0.17 on revs $184.3Mm vs est. $170.8Mm; guides FY revs $720-730Mm vs est. $702.7Mm Reta Pharma ($RETA) 2Q adj EPS ($1.32) vs est. ($2.06); reaffirms cash runway through mid-2024, reaffirms plan to submit MAA with EMA in 4Q21 for marketing approval of bardoxolone for treatment of CKD Rocket Pharma ($RCKT) Q2 EPS loss (-$0.55); expects its balance in cash equivalents and investments of $426.8 mln as of June 30, to fund its operations into 2H 2023 Shockwave Medical ($SWAV) Q2 EPS loss (-$0.01) vs. est. loss (-$0.41); Q2 revs $55.908M vs. est. $45.17M; raises FY21 revenue view $218M-$223M from $195M-$205M (est. $200.6M); Granted approval for a Transitional Pass-Through (TPT) payment for Shockwave C2 Coronary IVL device, which became effective July 1, 2021 for procedures in the outpatient setting SmileDirectClub ($SDC) 2Q EPS ($0.14) vs est. ($0.09) on revs $174Mm vs est. $198.5Mm; guides FY revs $750-800Mm vs est. $833.6Mm; Q2 average aligner gross sales price of $1,885 for Q2, compared to $1,817 for the second quarter of 2020 Steris Plc ($STE) Q1 adj EPS $1.76 vs. est. $1.49; Q1 revs $968.4M vs. est. $904.9M; now expects as reported revenue of approximately $4.6B in 2022, an increase from prior expectations of $4.5B; sees year EPS $7.60-$7.85 vs. est. $7.51; free cash flow for fiscal 2022 is now expected to be approximately $400 mln; raises dividend

127 Replies 11 πŸ‘ 13 πŸ”₯

Key Metrics

Market Cap

302.28 M

Beta

0.76

Avg. Volume

694.67 K

Shares Outstanding

40.85 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-09

Next Dividend Date

Company Information

Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases in areas of high unmet medical need. Fulcrum's proprietary product engine identifies drug targets which can modulate gene expression to treat the known root cause of gene mis-expression. The company has advanced losmapimod to Phase 2 clinical development for the treatment of facioscapulohumeral muscular dystrophy (FSHD). Fulcrum has also advanced FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and beta thalassemia into Phase 1 clinical development.

Website:

HQ: ,

Related News